Showing results (351-360 of 464) with videos related to

Sort By:
Pageof 47
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myelomaW I Bensinger, C D Buckner, R A Clift, et al.
Bone Marrow Transplantation|October 11, 2001
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimensF Gutierrez-Delgado, D G Maloney, O W Press, et al.
Neurology|August 1, 1986
Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host diseaseG B Bolger, K M Sullivan, A M Spence, et al.
Blood|October 1, 1993
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantationR A Clift, J A Bianco, F R Appelbaum, et al.
Annals of Internal Medicine|December 1, 1987
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantationJ D Meyers, N Flournoy, J E Sanders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's diseaseF R Appelbaum, K M Sullivan, E D Thomas, et al.
Bone Marrow Transplantation|September 1, 1989
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphomaF B Petersen, F R Appelbaum, C L Bigelow, et al.
Blood|March 1, 1986
Bone marrow transplantation in patients aged 45 years and olderH G Klingemann, R Storb, A Fefer, et al.
Annals of Internal Medicine|April 1, 1986
Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patientsC Anasetti, K C Doney, R Storb, et al.
Blood|December 1, 1996
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancyW I Bensinger, C D Buckner, K Shannon-Dorcy, et al.
Pageof 47